[*1]
Osman v Staten Is. Univ. Hosp.
2025 NY Slip Op 51751(U) [87 Misc 3d 1231(A)]
Decided on October 6, 2025
Supreme Court, Kings County
Frias-Colón, J.
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and will not be published in the printed Official Reports.


Decided on October 6, 2025
Supreme Court, Kings County


Nesin Osman, Plaintiff,

against

Staten Island University Hospital, Staten Island University Hospital,
a subsidiary of the North-Shore Long Island Jewish Health System Inc.,
Cynara Coomer, M.D., Jess Ting, M.D., and Lawrence Draper, M.D., Defendants.




Index No. 505512/2016


For Plaintiff:
Aaron Halpern of Silver & Kelmachter, LLP, 11 Park Place, Suite 1503, NY, NY 10007
212-661-8400 [email protected]

For Defendants Staten Island University Hospital et al.:
Gilbert Choi of Barker Patterson Nichols, LLP, 300 Garden City Plaza, Garden City, NY 11530
516-282-3355 [email protected]

For Defendant Jess Ting, M.D.:
Erin Deacy-Stalzer of Shaub, Ahmuty, Citrin & Spratt, LLP, 1983 Marcus Ave., Lake Success, NY 11042
516-488-3300 [email protected]


Patria Frias-Colón, J.

Recitation as per CPLR §§ 2219(a) and/or 3212(b) of papers considered on review of this motion:

NYSCEF Doc. Nos. 162-178; 207; 255 by Def. Ting
NYSCEF Doc. nos. 180-206; 251 by Defs. SIUH
NYSCEF Doc. Nos. 236-245 by Plaintiff

Upon review of the cited papers and after considering oral argument on March 25, 2025, pursuant to CPLR § 3212(b), the Court issues the following Decision/Order:

• Defendant Jess Ting, M.D.'s ("Dr. Ting") motion for summary judgment (Motion Sequence # 7) is DENIED.
• The joint motion by Defendants Staten Island University Hospital ("SIUH") and SIUH, a subsidiary of the North-Shore Long Island Jewish Health System, Inc. (collectively, "SIUH"), Cynara Coomer, M.D., and Lawrence Draper, M.D. (Motion Sequence # 8), is GRANTED IN PART, specifically, all claims against Dr. Coomer and Dr. Draper (and vicariously against SIUH) are DISMISSED. The remainder of their motion is DENIED.[FN1]

STANDARD OF REVIEW

Summary Judgment is a drastic remedy depriving a litigant of their day in court and should only be granted where there are no triable issues of fact. Bonaventura v. Galpin, 119 AD3d 625, 625 (2d Dept. 2014). The Court's role is not to resolve factual disputes or assess credibility, but simply to determine whether such issues exist. Stukas v. Streiter, 83 AD3d 18, 23 (2d Dept. 2011). In doing so, the evidence must be viewed in the light most favorable to the non-moving party. Pearson v. Dix McBride, LLC, 63 AD3d 895, 895 (2d Dept. 2009).

In medical malpractice cases, the essential elements are:

(1) a deviation or departure from accepted medical practice, and

(2) evidence that such departure was a proximate cause of the injury. Mendoza v. Maimonides Med. Ctr., 203 AD3d 715, 716 (2d Dept. 2022).

To establish a cause of action for lack of informed consent, a plaintiff must show:

(1) the provider failed to disclose alternatives and reasonably foreseeable risks that a reasonable practitioner would have disclosed,

(2) a reasonably prudent patient in the same position would not have undergone the treatment if fully informed, and

(3) the lack of informed consent is a proximate cause of the injury. Cox v. Herzog, 192 AD3d 757, 758 (2d Dept. 2021).

On a motion for summary judgment in a medical malpractice action, the defendant bears the initial burden of establishing either no departure from accepted medical practice or that any departure was not the proximate cause of the plaintiff's injury. Dye v. Okon, 203 AD3d 702, 703 (2d Dept. 2022). If the defendant meets this burden, the plaintiff must submit competent medical evidence to raise a triable issue of fact. Cerrone v. North Shore-Long Is. Jewish Health Sys., Inc., 197 AD3d 449, 450 (2d Dept. 2021). Where the parties submit conflicting expert opinions, summary judgment is inappropriate, as such credibility issues must be resolved by a jury. Gupta v. Lescale, 224 AD3d 668, 669 (2d Dept. 2024).

DISCUSSION

As to Defendant Jess Ting, M.D. (and vicariously SIUH):

The Court finds Dr. Ting failed to meet their burden under CPLR § 3212(b) to establish entitlement to summary judgment as a matter of law. The record presents multiple triable issues of fact, including, but not limited to:

(1) Preoperative Evaluation: whether Dr. Ting failed to properly evaluate and assess Plaintiff's vascular sufficiency in connection with the breast-reconstruction portion of the [*2]May 8, 2014 surgery.[FN2]
(2) Informed Consent: whether Dr. Ting failed to obtain informed consent from Plaintiff regarding the microsurgical deep inferior epigastric perforator ("DIEP") flap procedure, including whether he failed to adequately assess and advise her of the true risks associated with the DIEP flap and of alternative autologous surgical options that did not involve microvascular techniques.[FN3]
(3) Surgical Technique: whether Dr. Ting improperly performed the DIEP flap procedure by utilizing the superior inferior epigastric vein instead of the deep inferior epigastric vein, which provides greater venous return and is generally preferred.[FN4]
(4) Timing of Revision Surgery: whether Dr. Ting improperly assessed Plaintiff for the revision flap procedure performed on May 14, 2014, by proceeding without allowing sufficient time for the inflammatory process to resolve, thereby contributing to flap failure.[FN5]

As to Defendants Cynara Coomer, M.D. and Lawrence Draper, M.D. (and vicariously SIUH):

In contrast, Defendants Dr. Coomer and Dr. Draper have each demonstrated, prima facie, their entitlement to summary judgment as a matter of law. Their showing is supported by deposition testimony, medical records, and the detailed expert affirmations of board-certified specialists: Dr. Alison Eastabrook, M.D. (surgeon), Sheila M. Lemke, M.D. (internal medicine and oncology), Maurice Y. Nahabedian, M.D. (plastic surgeon), and Dr. Richard P. Fried, M.D. (infectious disease).[FN6]

As the Appellate Division has held, "[a]lthough physicians owe a general duty of care to their patients, that duty may be limited to those medical functions undertaken by the physician and relied on by the patient." Cooper v. City of New York, 200 AD3d 849 (2d Dept. 2021) [*3](internal quotation marks omitted), lv. denied 38 NY3d 908 (2022). The evidence establishes that Dr. Coomer's role was limited to surgical oncology and did not extend to the reconstructive phase of Plaintiff's care. No evidence suggests that Dr. Coomer assumed a duty to reconstruct Plaintiff's breasts following oncologic resection. See Abruzzi v. Maller, 221 AD3d 753, 756 (2d Dept. 2023).

Further, the record supports that Dr. Ting was the lead surgeon responsible for the breast reconstruction, with Dr. Draper serving in a subordinate, assisting capacity. Notably, it was Dr. Ting, not Dr. Draper, who both advocated and performed the extensive revision flap procedure on May 14, 2014.[FN7]

CONCLUSION

The Court considered the parties' remaining contentions and finds them either moot or without merit. All relief not expressly granted herein is denied.

Accordingly, it is hereby:

ORDERED that Defendant Dr. Ting's motion for summary judgment is denied.

It is further ORDERED that the joint motion of Defendants SIUH, Dr. Coomer, and Dr. Draper is granted to the extent that all claims against them are dismissed, and the remainder of their motion is denied.

It is further ORDERED that the caption of this action is amended to reflect the dismissal of Defendants Dr. Commer and Dr. Draper. It shall read as follows:


SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF KINGS

Nesin Osman,

Plaintiff,

against

Staten Island University Hospital, Staten Island
University Hospital, a subsidiary of the North-[*4]Shore
Long Island Jewish Health System, Inc., and Jess
Ting, M.D.,

Defendants.

This constitutes the Decision and Order of the Court.


Date: October 6, 2025
Brooklyn, New York
Hon. Patria Frias-Colón, J.S.C.

Footnotes


Footnote 1: The Court presumes the parties are well acquainted with the extensive record on these motions, which exceeds 3,300 pages.

Footnote 2: See NYSCEF Doc. # 238, Affirmation of Plaintiff's Expert Physician's in Opposition to the motions for summary judgment, affirmed February 10, 2025 ("Plaintiff's Expert Opposition"), ¶¶ 4(1), 22-24, and 46(1).

Footnote 3: Id. at ¶¶ 4(3), 9, 18, and 46(3). As explained by Plaintiff's Expert in ¶ 19 of the Opposition:
"[T]he DIEP flap procedure contemplated by [Dr.] Ting is an autologous microsurgical breast reconstruction procedure which utilizes the patient's own skin and subcutaneous tissue taken from the lower abdomen which is termed a 'flap' which is then transferred to the mastectomy area of the chest to reconstruct the breast. The blood flow to the flap is established using microsurgery to reconnect and anastomose blood vessel of the inferior epigastric artery to the artery and vein of the flap at the mastectomy site. The surgeon then shapes the flap to form a new breast" (emphasis added).

Footnote 4: See NYSCEF Doc. # 238, Plaintiff's Expert Opposition, ¶¶ 4(6), 35, and 46(6). As further explained by Plaintiff's Expert in ¶ 35:
"During the [breast-construction portion of surgery], [Dr.] Ting determined for the first time that [Plaintiff] 'had small perforators form the deep system bilaterally' which is a significant and concerning finding as it is finding consistent with insufficient blood supply for a DIEP flap.... Significantly, the record reflects that there were no anastomosis utilizing deep inferior epigastric veins. Instead, [Dr.] Ting decided to use the superficial inferior epigastric vein for anastomosis as the primary venous drainage for the flap which is not an accepted vein to utilize for this procedure for primary venous drainage. While the use of the superficial vein can be used to augment or salvage venous outflow if the deep venous inferior epigastric vein is compromised or insufficient, it is not used as the primary venous drainage because it has significantly reduced vascular flow compared to the deep inferior epigastric vein. Therefore, [Dr.] Ting's use of the superficial epigastric vein for anastomosis significantly reduced the venous drainage for the flap and it was a departure from accepted standard of care to utilize that vein for the anastomosis for that reason....[Dr.] Ting's use of the superficial epigastric vein for this procedure significantly reduced venous outflow which further increased the risk of clotting in the flap because of the physiological impact of reduced flow and increased resistance, thereby directly contributing to the flap's subsequent failure" (emphasis added).
Contrary to the contention raised by Dr. Ting's counsel in ¶ 29 of her Reply Affirmation, dated March 14, 2025 (NYSCEF Doc. # 255), the alleged misuse of the superior inferior epigastric vein in lieu of the deep inferior epigastric vein during the DIEP flap procedure falls within the scope of the broad allegations set forth in Plaintiff's Second Amended Verified Bill of Particulars as to Dr. Ting, dated March 21, 2024, ¶¶ 3(a)-(b), which allege a failure "to render medical, surgical,...[and] plastic surgery...in a safe manner and in conformity with accepted standards and practices" (NYSCEF Doc. # 154).

Moreover, as noted in ¶ 14 of Dr. Ting's Reply Affirmation, any alleged defects under to CPLR § 2309, such as the absence of a certificate of conformity, constitutes mere irregularities, not fatal defects, and may be properly disregarded absent a showing of actual prejudice. Carter v. U.S. Bank Tr., N.A., 217 AD3d 820, 821 (2d Dept. 2023).

Footnote 5: See NYSCEF Doc. # 238, Plaintiff's Expert Opposition, ¶¶ 4(8), 42-45, and 46(8). As noted by Plaintiff's Expert in ¶ 43:
"[I]t was [a] significant departure from accepted standards of medical care to offer [to, and perform on,] [Plaintiff] an immediate latissimus dorsi flap reconstruction on May 14, 2014...[shortly] after...the catastrophic left flap failure in which the patient was suffering from a serious inflammatory, infectious and necrotic process...." (emphasis added).
In that regard, Plaintiff's expert further observed in ¶ 20 that a latissimus dorsi flap, which involves the removal and grafting of muscle tissue, such as the rectus abdominus muscle that contains its own intrinsic blood supply, should have been offered to Plaintiff during the initial breast-reconstruction portion of the May 8, 2014 surgery. According to the expert, this option would have been more appropriate than the microsurgical DIEP flap procedure, which, unlike a latissimus dorsi flap, relies on an external primary blood supply.

Footnote 6: See NYSCEF Doc. Nos. 203-206: Expert Affirmation of Alison Eastabrook, M.D., dated May 24, 2024; Expert Affirmation of Sheila A. Lemke, M.D., dated May 15, 2024; Expert Affirmation of Maurice Y. Nahabedian, M.D., dated May 15, 2024; and Expert Affirmation of Richard P. Fried, M.D., dated May 24, 2024, respectively.

Footnote 7: As Plaintiff's Expert acknowledged (in ¶¶ 41-42 and 44 of his Opposition):
"After assessing that the left flap had failed and necrosed, [Dr.] Draper offered to remove the necrotic left breast flap and close the left breast wound with delayed reconstruction.

However, [Dr.] Ting's assessment was different in that he offered [Plaintiff] an immediate latissimus dorsi flap reconstruction as an available and accepted treatment option, as an alternative to the removal of the left flap with delayed reconstruction.

[T]he only appropriate reconstruction option for [Plaintiff] at that time was a delayed breast reconstruction to allow the inflammation and inflammatory process to resolve which could take several months. Failing to allow [Plaintiff] to properly heal prior to attempting a further reconstruction procedure which would essentially involve transferring healthy tissue to a significantly inflamed and infected chest area would doom the reconstruction procedure to fail as what occurred with regard to [Dr.] Ting's May 14, 2014 procedure" (emphasis added in each instance).